Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in China. It is testing Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets for depression.
In HangzhouThis study is completed in China. It is testing Toluedesvenlafaxine Hydrochloride Extended-release Tablets for depression.
In ShanghaiThis study is completed in the United States. It is testing topiramate for Eating disorders.
In BostonThis study is completed in the United States and in Spain. It is testing TV-1380 for Addiction.
Multiple locations, including Los AngelesThis study is completed in the United States, in India, and in Romania. It is testing two Atypical Antipsychotics for schizophrenia.
Multiple locations, including San DiegoThis study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including AnaheimThis study is completed in the United States. It is testing troriluzole for OCD.
Multiple locations, including ChandlerThis study is completed in China. It focuses on schizophrenia.
Multiple locations, including GuangzhouThis study is completed in the United States. It is testing BHV-7000 Monotherapy for depression.
Multiple locations, including PhoenixThis study was terminated in the United States. It is testing clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo for schizophrenia.
In IndianapolisThis study is completed in South Korea. It is testing combination of Ginkgo Extract and Ginseng Extract for ADHD.
Multiple locations, including Anyang-siThis study is completed in South Korea. It focuses on ADHD.
Multiple locations, including Anyang-siHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.